Morgan Stanley’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.01M | Buy |
|
|||||
|
2022
Q4 | $3.88M | Sell |
|
|||||
|
2022
Q3 | $4.22M | Sell |
|
|||||
|
2022
Q2 | $5.2M | Buy |
|
|||||
|
2022
Q1 | $338K | Sell |
|
|||||
|
2021
Q4 | $247K | Sell |
|
|||||
|
2021
Q3 | $1.64M | Sell |
|
|||||
|
2021
Q2 | $2.66M | Sell |
|
|||||
|
2021
Q1 | $4.27M | Buy |
|
|||||
|
2020
Q4 | $1.22M | Buy |
|
|||||
|
2020
Q3 | $9K | Buy |
|
|||||
|
2020
Q2 | $2K | Sell |
|
|||||
|
2020
Q1 | $4K | Sell |
|
|||||
|
2019
Q4 | $26K | Buy |
|
|||||
|
2019
Q3 | $13K | Buy |
|
|||||
|
2019
Q2 | $6K | Sell |
|
|||||
|
2019
Q1 | $20K | Sell |
|
|||||
|
2018
Q4 | $101K | Buy |
|
|||||
|
2018
Q3 | $190K | Sell |
|
|||||
|
2018
Q2 | $565K | Buy |
|
|||||
|
2018
Q1 | $273K | Buy |
|
|||||
|
2017
Q4 | $101K | Sell |
|
|||||
|
2017
Q3 | $150K | Buy |
|
|||||
|
2017
Q2 | $127K | Sell |
|
|||||
|
2017
Q1 | $243K | Buy |
|
|||||
|
2016
Q4 | $18K | Sell |
|
|||||
|
2016
Q3 | $37K | Buy |
|
|||||
|
2016
Q2 | $17K | Sell |
|
|||||
|
2016
Q1 | $35K | Buy |
|
|||||
|
2015
Q4 | $49K | Sell |
|
|||||
|
2015
Q3 | $88K | Sell |
|
|||||
|
2015
Q2 | $125K | Sell |
|
|||||
|
2015
Q1 | $127K | Sell |
|
|||||
|
2014
Q4 | $169K | Buy |
|
|||||
|
2014
Q3 | $115K | Sell |
|
|||||
|
2014
Q2 | $214K | Sell |
|
|||||
|
2014
Q1 | $1.82M | Buy |
|
|||||
|
2013
Q4 | $94K | Sell |
|
|||||
|
2013
Q3 | $366K | Sell |
|
|||||
|
2013
Q2 | $509K | Buy |
|